Published by Coherent Market Insights
Posted on September 20, 2021
3 min readLast updated: February 5, 2026
The pharmaceutical anti-counterfeiting market is expanding due to increased demand for drug security technologies amid rising counterfeit incidents.
Worldwide, pharmaceutical products are one of the most vulnerable goods to counterfeiting practices. According to the World Health Organization (WHO), Pharmaceutical counterfeiting is a serious, pervasive threat; fake drugs drain the global economy of as much as $ 200 billion in lost profits annually. It is an issue with potentially deadly consequences. Therefore, there is an increasing demand for pharmaceutical anti-counterfeiting technologies all around the world, driving the growth of the pharmaceutical anti-counterfeiting technologies market. For example, in June 2021, Honeywell launched the digital authentication technology for the pharmaceutical industry in response to the growing menace of counterfeit products.
The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/1747
An acute shortage of drugs to treat symptoms of COVID-19 (coronavirus) has led to increased circulation of counterfeit medicines in recent times, according to the company. Pharmaceutical companies have employed several analytical techniques for the detection of counterfeits. They include techniques like colorimetry and thin-layer chromatography, NMR, mass, and Raman spectroscopies. The pandemic has heightened the dangers posed by counterfeit pharmaceutical products. According to the Authentication Solution Providers’ Association (ASPA), a sharp spike has been witnessed in counterfeiting of pharmaceutical products during the pandemic, especially sanitizers and PPE kits.
Moreover, according to the same source, counterfeiting incidents in India have risen rapidly in the last few years, with a 20% growth from January 2018 to December 2020. This in turn is expected to increase the demand for pharmaceutical anti-counterfeiting technologies, driving the pharmaceutical anti-counterfeiting technologies market growth, especially in India. Anti-counterfeiting technologies are of various types such as forensic technologies, track and trace technologies, overt technologies, and cohort technologies. Rising incidents of counterfeiting affect patient health and overall human capital. Moreover, these counterfeit products score low on quality and therefore affect the image of the manufacturer.
According to the U.S. Food and Drug Administration (FDA), pharmaceutical manufacturers in the United States entail an approximate revenue loss of US$ 300 billion every year owing to counterfeiting. Thus, losses in terms of revenue and increasing focus on brand protection to reduce pharmaceutical counterfeiting coupled with the growing awareness regarding anti-counterfeiting technologies is expected to increase demand for anti-counterfeiting technologies in this region. This in turn is expected to augment the growth of the pharmaceutical anti-counterfeiting technologies market in the U.S. However, the high setup cost and existence of technologies that are non-deterrent to counterfeiters are some major factors expected to restrain the growth of the pharmaceutical anti-counterfeiting technologies market.
Top Key Players Include In Pharmaceutical Anti-counterfeiting Technologies Market: Alien Technology, Alpvision, Robert Bosch GmbH, 3M Company, Angstrom Technologies, Thermo Fisher Scientific, Authentix, Inc., Avery Dennison Corporation, Colorcon, Covectra, and Everest Holovisions Ltd.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1747
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Pharmaceutical Anti-counterfeiting Technologies Market to Grow at a Significant Rate During the Forecast Period | Coherent Market Insights appeared first on Gatorledger.
The article discusses the growth of the pharmaceutical anti-counterfeiting technologies market.
Rising counterfeit drug incidents and economic losses drive demand for anti-counterfeiting technologies.
High setup costs and non-deterrent technologies are major challenges for market growth.
Explore more articles in the Research Reports category
